| Analysis | Metabolite Name | Measured Value | Units | Strain | Treatment |
|---|---|---|---|---|---|
| NEGATIVE ION MODE | L-TYROSINE | 170000 | Peak area | CRBN +/+ | anti-CD3 stimulation |
| NEGATIVE ION MODE | L-TYROSINE | 173000 | Peak area | CRBN +/+ | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | L-TYROSINE | 224000 | Peak area | CRBN -/- | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | L-TYROSINE | 231000 | Peak area | CRBN -/- | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | L-TYROSINE | 253000 | Peak area | CRBN -/- | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | L-TYROSINE | 260000 | Peak area | CRBN +/+ | anti-CD3 stimulation |
| NEGATIVE ION MODE | L-TYROSINE | 291000 | Peak area | CRBN -/- | unstimulated |
| NEGATIVE ION MODE | L-TYROSINE | 301000 | Peak area | CRBN +/+ | anti-CD3 stimulation |
| NEGATIVE ION MODE | L-TYROSINE | 313000 | Peak area | CRBN -/- | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | L-TYROSINE | 323000 | Peak area | CRBN -/- | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | L-TYROSINE | 360000 | Peak area | CRBN -/- | anti-CD3 stimulation |
| NEGATIVE ION MODE | L-TYROSINE | 382000 | Peak area | CRBN -/- | anti-CD3 stimulation |
| NEGATIVE ION MODE | L-TYROSINE | 422000 | Peak area | CRBN -/- | unstimulated |
| NEGATIVE ION MODE | L-TYROSINE | 429000 | Peak area | CRBN +/+ | anti-CD3 stimulation |
| NEGATIVE ION MODE | L-TYROSINE | 452000 | Peak area | CRBN +/+ | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | L-TYROSINE | 476000 | Peak area | CRBN -/- | unstimulated |
| NEGATIVE ION MODE | L-TYROSINE | 497000 | Peak area | CRBN -/- | anti-CD3 stimulation |
| NEGATIVE ION MODE | L-TYROSINE | 525000 | Peak area | CRBN -/- | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | L-TYROSINE | 533000 | Peak area | CRBN -/- | unstimulated |
| NEGATIVE ION MODE | L-TYROSINE | 536000 | Peak area | CRBN +/+ | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | L-TYROSINE | 537000 | Peak area | CRBN +/+ | unstimulated |
| NEGATIVE ION MODE | L-TYROSINE | 541000 | Peak area | CRBN -/- | anti-CD3 stimulation |
| NEGATIVE ION MODE | L-TYROSINE | 546000 | Peak area | CRBN +/+ | anti-CD3 stimulation |
| NEGATIVE ION MODE | L-TYROSINE | 587000 | Peak area | CRBN +/+ | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | L-TYROSINE | 611000 | Peak area | CRBN +/+ | unstimulated |
| NEGATIVE ION MODE | L-TYROSINE | 638000 | Peak area | CRBN -/- | unstimulated |
| NEGATIVE ION MODE | L-TYROSINE | 645000 | Peak area | CRBN -/- | anti-CD3 stimulation |
| NEGATIVE ION MODE | L-TYROSINE | 660000 | Peak area | CRBN +/+ | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | L-TYROSINE | 700000 | Peak area | CRBN +/+ | unstimulated |
| NEGATIVE ION MODE | L-TYROSINE | 709000 | Peak area | CRBN -/- | unstimulated |
| NEGATIVE ION MODE | L-TYROSINE | 724000 | Peak area | CRBN +/+ | anti-CD3 stimulation |
| NEGATIVE ION MODE | L-TYROSINE | 761000 | Peak area | CRBN -/- | anti-CD3 stimulation |
| NEGATIVE ION MODE | L-TYROSINE | 823000 | Peak area | CRBN -/- | unstimulated |
| NEGATIVE ION MODE | L-TYROSINE | 829000 | Peak area | CRBN +/+ | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | L-TYROSINE | 859000 | Peak area | CRBN +/+ | anti-CD3 stimulation |
| NEGATIVE ION MODE | L-TYROSINE | 890000 | Peak area | CRBN -/- | anti-CD3 stimulation |
| NEGATIVE ION MODE | L-TYROSINE | 934000 | Peak area | CRBN -/- | unstimulated |
| NEGATIVE ION MODE | L-TYROSINE | 1120000 | Peak area | CRBN +/+ | anti-CD3 stimulation |
| NEGATIVE ION MODE | L-TYROSINE | 1190000 | Peak area | CRBN +/+ | unstimulated |
| NEGATIVE ION MODE | L-TYROSINE | 1200000 | Peak area | CRBN -/- | anti-CD3 stimulation |
| NEGATIVE ION MODE | L-TYROSINE | 1200000 | Peak area | CRBN +/+ | unstimulated |
| NEGATIVE ION MODE | L-TYROSINE | 1290000 | Peak area | CRBN +/+ | unstimulated |
| NEGATIVE ION MODE | L-TYROSINE | 1350000 | Peak area | CRBN -/- | unstimulated |
| NEGATIVE ION MODE | L-TYROSINE | 1390000 | Peak area | CRBN -/- | unstimulated |
| NEGATIVE ION MODE | L-TYROSINE | 1570000 | Peak area | CRBN +/+ | unstimulated |
| NEGATIVE ION MODE | L-TYROSINE | 1710000 | Peak area | CRBN -/- | anti-CD3 stimulation |
| NEGATIVE ION MODE | L-TYROSINE | 1790000 | Peak area | CRBN -/- | anti-CD3 stimulation |
| NEGATIVE ION MODE | L-TYROSINE | 2080000 | Peak area | CRBN +/+ | unstimulated |
| NEGATIVE ION MODE | L-TYROSINE | 2160000 | Peak area | CRBN -/- | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | L-TYROSINE | 2180000 | Peak area | CRBN +/+ | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | L-TYROSINE | 2640000 | Peak area | CRBN +/+ | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | L-TYROSINE | 3510000 | Peak area | CRBN +/+ | anti-CD3 stimulation |
| NEGATIVE ION MODE | L-TYROSINE | 5380000 | Peak area | CRBN +/+ | anti-CD3 stimulation |
| NEGATIVE ION MODE | L-TYROSINE | 5450000 | Peak area | CRBN +/+ | unstimulated |
| NEGATIVE ION MODE | L-TYROSINE | 7970000 | Peak area | CRBN -/- | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | L-TYROSINE | 8380000 | Peak area | CRBN -/- | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | L-TYROSINE | 8850000 | Peak area | CRBN -/- | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | L-TYROSINE | 9780000 | Peak area | CRBN +/+ | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | L-TYROSINE | 15600000 | Peak area | CRBN +/+ | unstimulated |
| NEGATIVE ION MODE | L-TYROSINE | 15800000 | Peak area | CRBN +/+ | anti-CD3 & anti-CD28 stimulation |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|